Skip to content

Orphan Drug Company Genzyme’s 2012 Patient Advocacy Leadership (PAL) Awards

October 5, 2012

       On October 1, 2012, Genzyme announces winners of the Patient Advocacy Leadership (PAL) Awards. This program supports outreach programs by non-profit organizations that provide support for patients living with lysosomal storage disorders (LSDs). LSD is a group of rare inherited diseases that are usually progressive resulting in debilitating health.   

       The statistics for the 2nd Annual PAL Award programs are :

  1. > 50 patient organizations participated
  2. 27 countries represented
  3. 9 recipients received the PAL Awards
  4. > $100,000 was awarded. 

       The PAL Awards support advocacy groups with the purpose of  “raising awareness & supporting rare disease communities …… efforts to raise awareness using the internet, family education, collaboration with healthcare providers ……”.


Genzyme Rare Community Blog

Genzyme PAL Awards website

Copyright © 2012-2013, Ann-Teresa Cusenza and Orphan Druganaut Blog.  All rights reserved.

From → Genzyme, Sanofi

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: